Similar articles for PMID: 22312157

Year	Number of Results
1991	1
1996	1
1997	1
1999	3
2000	3
2001	1
2002	6
2003	6
2004	3
2005	4
2006	3
2007	5
2008	9
2009	8
2010	9
2011	16
2012	14
2013	13
2014	19
2015	9
2016	7
2017	7
2018	3
2019	2
2020	2
2021	2
2022	3
2024	0

1

Summaries for patients: Oral drug treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians.

[No authors listed] [No authors listed] Ann Intern Med. 2012 Feb 7;156(3):I36. doi: 10.7326/0003-4819-156-3-201202070-00004. Ann Intern Med. 2012. PMID: 22312157 Free article. No abstract available.

2

Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians.

Qaseem A, Humphrey LL, Sweet DE, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Qaseem A, et al. Ann Intern Med. 2012 Feb 7;156(3):218-31. doi: 10.7326/0003-4819-156-3-201202070-00011. Ann Intern Med. 2012. PMID: 22312141 Free article.

3

Saxagliptin + metformin. Mostly disadvantages.

[No authors listed] [No authors listed] Prescrire Int. 2013 Feb;22(135):40. Prescrire Int. 2013. PMID: 23444500 No abstract available.

4

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians.

Qaseem A, Barry MJ, Humphrey LL, Forciea MA; Clinical Guidelines Committee of the American College of Physicians; Fitterman N, Horwitch C, Kansagara D, McLean RM, Wilt TJ. Qaseem A, et al. Ann Intern Med. 2017 Feb 21;166(4):279-290. doi: 10.7326/M16-1860. Epub 2017 Jan 3. Ann Intern Med. 2017. PMID: 28055075 Free article.

5

[New class of oral antidiabetic drugs. Effective in combination with metformin].

[No authors listed] [No authors listed] MMW Fortschr Med. 2007 Jan;149(1-2):17. MMW Fortschr Med. 2007. PMID: 17619359 German. No abstract available.

6

Metformin/Repaglinide (PrandiMet) for type 2 diabetes.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2009 Jun 1;51(1313):41-3. Med Lett Drugs Ther. 2009. PMID: 19478691 No abstract available.

7

[Early insulin treatment in type 2 diabetes--yes].

Schumm-Draeger PM. Schumm-Draeger PM. Dtsch Med Wochenschr. 2013 May;138(18):956. doi: 10.1055/s-0032-1332975. Epub 2013 Apr 23. Dtsch Med Wochenschr. 2013. PMID: 23613375 German. No abstract available.

8

Cost-effectiveness analysis of dapagliflozin treatment versus metformin treatment in Chinese population with type 2 diabetes.

Cai X, Shi L, Yang W, Gu S, Chen Y, Nie L, Ji L. Cai X, et al. J Med Econ. 2019 Apr;22(4):336-343. doi: 10.1080/13696998.2019.1570220. Epub 2019 Feb 4. J Med Econ. 2019. PMID: 30663458 Free article.

9

Monitoring safety and effectiveness in patients receiving metformin.

Choe HM, Cornish L, Townsend K, Jobe J, Mitrovich S. Choe HM, et al. Am J Health Syst Pharm. 2004 Aug 1;61(15):1550-1. doi: 10.1093/ajhp/61.15.1550. Am J Health Syst Pharm. 2004. PMID: 15372824 No abstract available.

10

Summaries for patients: Does adding exenatide to insulin treatment benefit patients with type 2 diabetes?

[No authors listed] [No authors listed] Ann Intern Med. 2011 Jan 18;154(2):I-40. doi: 10.7326/0003-4819-154-2-201101180-00301. Epub 2010 Dec 6. Ann Intern Med. 2011. PMID: 21135289 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

149 results

Results by year